Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Completed
Medicis Pharmaceutical Corporation
Phase 2/Phase 3
2009-02-01
The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin
0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea
Completed
Massachusetts General Hospital
Phase 2/Phase 3
2009-02-01
The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin
0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne
Completed
GlaxoSmithKline
Phase 4
2009-08-01
One of the main success factors in acne therapy is user compliance with treatment, product
cost, availability and ease of use. Poor compliance may translate into decreased efficacy
(either not improving symptoms well enough or not improving symptoms fast enough),
tolerability issues or adverse effects (eg, erythema, dryness, or peeling of the skin), a
lack of understanding of the instructions for use, or product cost/availability. Whatever the
reason, poor compliance translates to decreased efficacy and increased frustration on the
part of the user.
The current study will evaluate the efficacy and tolerability of MAXCLARITY II, an over the
counter, topical benzoyl peroxide (BPO) product line, in subjects with acne.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
